Wolverine Trading’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,915
Closed -$49.6K 5554
2024
Q4
$54.6K Buy
+10,915
New +$51.1K ﹤0.01% 4965
2022
Q1
Sell
-8,822
Closed -$229K 6187
2021
Q4
$229K Buy
+8,822
New +$244K ﹤0.01% 4513
2021
Q3
Sell
-19,650
Closed -$566K 6766
2021
Q2
$670K Buy
19,650
+12,481
+174% +$396K ﹤0.01% 3286
2021
Q1
$238K Buy
+7,169
New +$249K ﹤0.01% 4805
2020
Q4
Sell
-13,187
Closed -$406K 5301
2020
Q3
$414K Sell
13,187
-2,051
-13% -$67.9K ﹤0.01% 3022
2020
Q2
$507K Sell
15,238
-2,649
-15% -$92K ﹤0.01% 2706
2020
Q1
$497K Buy
+17,887
New +$469K ﹤0.01% 2668
2019
Q3
Sell
-20,510
Closed -$339K 4846
2019
Q2
$321K Buy
20,510
+1,242
+6% +$24.4K ﹤0.01% 3200
2019
Q1
$439K Sell
19,268
-1,140
-6% -$25.7K ﹤0.01% 2921
2018
Q4
$486K Buy
+20,408
New +$545K ﹤0.01% 2660
2018
Q1
Sell
-24,407
Closed -$1.11M 5662
2017
Q4
$1.11M Buy
24,407
+7,581
+45% +$299K ﹤0.01% 2099
2017
Q3
$558K Buy
16,826
+5,919
+54% +$241K ﹤0.01% 2494
2017
Q2
$442K Buy
+10,907
New +$338K ﹤0.01% 2567

Other funds holding PETS

Wolverine Trading's PETS Position: Q1 2025 in Review

Wolverine Trading sold out of PetMed Express (PETS) in Q1 2025, closing a stake of 10,915 shares — an estimated $49.6K sold.

Wolverine Trading first reported a position in PETS in Q2 2017 and held it in 13 quarters. The position peaked at $1.11M in Q4 2017. 72 funds tracked by Wall St. Rank hold PETS as of Q1 2025.

  • Wolverine Trading reported no remaining PetMed Express position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 10,915 PetMed Express shares in Q1 2025, an estimated $49.6K.
  • Wolverine Trading first reported a position in PetMed Express in Q2 2017 and held it in 13 quarters.
  • Wolverine Trading's PetMed Express position peaked at $1.11M in Q4 2017.
  • 72 funds tracked by Wall St. Rank held PetMed Express as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.